Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.53 USD | +0.78% | +6.12% | +7.33% |
03-20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
03-20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Sales 2024 * | 1.21B 96.78B | Sales 2025 * | 1.27B 101B | Capitalization | 3.01B 241B |
---|---|---|---|---|---|
Net income 2024 * | 57M 4.56B | Net income 2025 * | 197M 15.77B | EV / Sales 2024 * | 2.4 x |
Net cash position 2024 * | 102M 8.18B | Net cash position 2025 * | 231M 18.46B | EV / Sales 2025 * | 2.19 x |
P/E ratio 2024 * |
46
x | P/E ratio 2025 * |
33.3
x | Employees | 2,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.44% |
Latest transcript on LivaNova PLC
1 day | +0.78% | ||
1 week | +6.12% | ||
Current month | -0.73% | ||
1 month | -0.61% | ||
3 months | +12.09% | ||
6 months | +17.67% | ||
Current year | +7.33% |
Managers | Title | Age | Since |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 31/12/16 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 07/01/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02/12/20 | |
Peter Wilver
BRD | Director/Board Member | 64 | 12/06/22 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 55.53 | +0.78% | 553,327 |
25/04/24 | 55.1 | -1.50% | 536,705 |
24/04/24 | 55.94 | +1.67% | 977,319 |
23/04/24 | 55.02 | +1.87% | 661,198 |
22/04/24 | 54.01 | +3.21% | 733,740 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.33% | 3.01B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- LIVN Stock